TGFalpha Promotes Growth of Lung Tumors Carrying EGFR Mutation but not KRAS Mutation in Transgenic Mouse Models in Vivo

被引:0
|
作者
Tomoshige, K. [1 ]
Minzhe, G. [2 ]
Tsuchiya, T. [1 ]
Fukazawa, T. [3 ]
Naomoto, Y. [3 ]
Nagayasu, T. [1 ]
Maeda, Y. [2 ]
机构
[1] Nagasaki Grad Sch Med, Surg Oncol, Nagasaki, Japan
[2] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA
[3] Kawasaki Med Sch, Gen Surg, Okayama, Japan
关键词
KRAS; TGFalpha; EGFR;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P1.02-014
引用
收藏
页码:S1928 / S1928
页数:1
相关论文
共 50 条
  • [41] Biological and clinical significance of KRAS mutations in lung cancer: an oncogenic driver that contrasts with EGFR mutation
    Suda, Kenichi
    Tomizawa, Kenji
    Mitsudomi, Tetsuya
    [J]. CANCER AND METASTASIS REVIEWS, 2010, 29 (01) : 49 - 60
  • [42] Biological and clinical significance of KRAS mutations in lung cancer: an oncogenic driver that contrasts with EGFR mutation
    Kenichi Suda
    Kenji Tomizawa
    Tetsuya Mitsudomi
    [J]. Cancer and Metastasis Reviews, 2010, 29 : 49 - 60
  • [43] Extraordinary Response to Erlotinib Therapy in a Patient with Lung Adenocarcinoma Exhibiting KRAS Mutation and EGFR Amplification
    Krejci, J.
    Pesek, M.
    Grossmann, P.
    Krejci, M.
    Ricar, J.
    Benesova, L.
    Minarik, M.
    [J]. CANCER GENOMICS & PROTEOMICS, 2011, 8 (03) : 135 - 138
  • [44] EGFR and KRAS mutation analysis in cytologic samples of lung adenocarcinoma enabled by laser capture microdissection
    Chowdhuri, Sinchita Roy
    Xi, Liqiang
    Trinh Hoc-Tran Pham
    Hanson, Jeffrey
    Rodriguez-Canales, Jaime
    Berman, Arlene
    Rajan, Arun
    Giaccone, Giuseppe
    Emmert-Buck, Michael
    Raffeld, Mark
    Filie, Armando C.
    [J]. MODERN PATHOLOGY, 2012, 25 (04) : 548 - 555
  • [45] Elderly male smokers with right lung tumors are viable candidates for KRAS mutation screening
    Yang Yang
    Chun Shi
    Hui Sun
    Wei Yin
    Xiao Zhou
    Lei Zhang
    Gening Jiang
    [J]. Scientific Reports, 6
  • [46] Elderly male smokers with right lung tumors are viable candidates for KRAS mutation screening
    Yang, Yang
    Shi, Chun
    Sun, Hui
    Yin, Wei
    Zhou, Xiao
    Zhang, Lei
    Jiang, Gening
    [J]. SCIENTIFIC REPORTS, 2016, 6
  • [47] Ciliated muconodular papillary tumors of the lung with KRAS/BRAF/AKT1 mutation
    Udo, Emiko
    Furusato, Bungo
    Sakai, Kazuko
    Prentice, Leah M.
    Tanaka, Tomonori
    Kitamura, Yuka
    Tsuchiya, Tomoshi
    Yamasaki, Naoya
    Nagayasu, Takeshi
    Nishio, Kazuto
    Fukuoka, Junya
    [J]. DIAGNOSTIC PATHOLOGY, 2017, 12
  • [48] Ciliated muconodular papillary tumors of the lung with KRAS/BRAF/AKT1 mutation
    Emiko Udo
    Bungo Furusato
    Kazuko Sakai
    Leah M Prentice
    Tomonori Tanaka
    Yuka Kitamura
    Tomoshi Tsuchiya
    Naoya Yamasaki
    Takeshi Nagayasu
    Kazuto Nishio
    Junya Fukuoka
    [J]. Diagnostic Pathology, 12
  • [49] Comparison of CISH and FISH for detection of EGFR copy number in lung adenocarcinomas and correlation with EGFR and KRAS mutation status and EGFR immunohistochemistry reactivity
    Varella, Garcia Marileila
    Ladanyi, Marc
    Kris, Mark G.
    Rekhtman, Natasha
    Hirsch, Fred
    Miller, Vincent
    Riely, Gregory
    Pao, William
    Zakowski, Maureen F.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S341 - S341
  • [50] Schedule-dependent antitumor activity of the combination with erlotinib and docetaxel in human non-small cell lung cancer cells with EGFR mutation, KRAS mutation or both wild-type EGFR and KRAS
    Furugaki, Koh
    Iwai, Toshiki
    Shirane, Masatoshi
    Kondoh, Kumiko
    Moriya, Yoichiro
    Mori, Kazushige
    [J]. ONCOLOGY REPORTS, 2010, 24 (05) : 1141 - 1146